Felix Hermann, PhD apceth Biopharma

Felix Hermann, PhD

Felix Hermann, PhD apceth Biopharma

Felix Hermann is Head of Research and Development at apceth Biopharma GmbH. In his current position, Felix is leading the preclinical development team as well as the Pharmaceutical technical development team at apceth.

His responsibilities include the generation and preclinical evaluation of product candidates based on genetically engineered mesenchymal stem cells. Furthermore, he is responsible for the development of manufacturing processes and analytical methods for clinical product candidates.

Felix has more than 15 years of experience in the field of cell based gene therapy. In his previous position as senior scientist at Vision 7 GmbH, he worked on the preclinical development of a hematopoietic stem cell based gene therapy approaches for the treatment of HIV. He has considerable expertise in design and generation of gamma-retroviral and lentiviral vectors.

Felix holds a Master’s degree and a PhD in Biology. His thesis was focused on a T cell based gene therapy approach for HIV infection.